Clinigen Group PLC (CLIN) Receives Buy Rating from Peel Hunt
Separately, Numis Securities Ltd downgraded shares of Clinigen Group PLC to an add rating and set a GBX 1,100 ($14.52) price target for the company. in a research report on Tuesday, July 18th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Clinigen Group PLC presently has a consensus rating of Buy and an average target price of GBX 1,103 ($14.56).
Clinigen Group PLC (CLIN) opened at 1176.00 on Tuesday. The firm has a 50-day moving average of GBX 1,108.97 and a 200-day moving average of GBX 978.53. Clinigen Group PLC has a 52 week low of GBX 695.00 and a 52 week high of GBX 1,187.00. The company’s market cap is GBX 1.35 billion.
Clinigen Group PLC (LON:CLIN) last announced its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.55) EPS for the quarter, topping the consensus estimate of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). The company had revenue of £302.30 million during the quarter. Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%.
The firm also recently declared a dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be given a GBX 3.40 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, November 9th. This represents a yield of 0.32%. This is an increase from Clinigen Group PLC’s previous dividend of $1.60.
In related news, insider John Bacon sold 250,000 shares of Clinigen Group PLC stock in a transaction on Monday, October 2nd. The shares were sold at an average price of GBX 1,093 ($14.42), for a total value of £2,732,500 ($3,605,832.67). Also, insider Shaun Edward Chilton sold 100,000 shares of Clinigen Group PLC stock in a transaction on Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.18), for a total transaction of £1,150,000 ($1,517,550.80).
Clinigen Group PLC Company Profile
Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.